MicroRNAs as potential cancer therapeutics
- 3 December 2008
- journal article
- review article
- Published by Springer Nature in Oncogene
- Vol. 27 (S2) , S52-S57
- https://doi.org/10.1038/onc.2009.353
Abstract
MicroRNAs (miRNAs) have been shown to have an important role in various cellular processes, such as apoptosis, differentiation and development. Recent studies have shown that miRNAs are mis-expressed in human cancers where they can exert their effect as oncogenes or tumor suppressors. Here, we review the potential for using miRNAs as biomarkers for diagnosis, prognosis and cancer therapies.Keywords
This publication has 68 references indexed in Scilit:
- Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer ModelCell, 2009
- AngiomiRs—Key regulators of angiogenesisCurrent Opinion in Genetics & Development, 2009
- The mir-34 microRNA is required for the DNA damage response in vivo in C. elegans and in vitro in human breast cancer cellsOncogene, 2009
- RETRACTED: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancerGynecologic Oncology, 2008
- Widespread microRNA repression by Myc contributes to tumorigenesisNature Genetics, 2007
- Oncomirs — microRNAs with a role in cancerNature Reviews Cancer, 2006
- Silencing of microRNAs in vivo with ‘antagomirs’Nature, 2005
- MicroRNA expression profiles classify human cancersNature, 2005
- c-Myc-regulated microRNAs modulate E2F1 expressionNature, 2005
- A microRNA polycistron as a potential human oncogeneNature, 2005